<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="../css/strict.xsl"?>
<PAGE status="unmaintained" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="../css/schema.xsd">
<TITLE>Clinical Trial Market</TITLE>
<PATH>links/clintrials.xml</PATH>
<DATE><YEAR>2015</YEAR><MONTH>2</MONTH><DAY>15</DAY></DATE>
<CONTENT>
<LLIST>
  <ITEM><SLIST>
    <ITEM><BLIST><TITLE>CROs</TITLE>
      <ITEM><BLIST><TITLE>Lists</TITLE>
        <ITEM><X><T>Wikipedia</T><A>https://en.wikipedia.org/wiki/Contract_Research_Organization</A><L>en</L><F>HTML</F></X></ITEM>
      </BLIST></ITEM>
      <ITEM><X><T>4clinics</T><A>http://www.4clinics.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>ADDS</T><A>http://www.adds.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Alcami</T><A>https://www.alcaminow.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Altizem</T><A>https://altizem.com/</A><L>fr</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Aris Global</T><A>https://arisglobal.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X status='dead'><T>Ascopharm</T><A>http://www.ascopharm.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Axonal</T><A>http://www.axonal.fr</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Baim Institute</T><A>https://www.baiminstitute.org/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Business &amp; Decision Life Sciences</T><A>https://www.businessdecision-lifesciences.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Cardiαlysis</T><A>https://www.cardialysis.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Cato SMS</T><A>https://www.cato-sms.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Cemka Eval</T><A>https://www.cemka.fr/</A><L>fr</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Cemo</T><A>http://www.cemo.fr</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Charles River</T><A>https://www.criver.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Chiltern International</T><A>https://www.chiltern.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Clinact</T><A>https://www.clinact.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Clinical Data</T><A>https://www.google.com/search?q=%22clinical+data%22+laon</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>ClinSearch</T><A>https://www.clinsearch.net/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Clinsys Clinical Research</T><A>https://www.clinsys.net/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Covance</T><A>https://www.covance.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>C-Tasc</T><A>http://www.c-tasc.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X status='dead'><T>DCI</T><A>http://www.dci-france.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Debioclinic</T><A>https://www.debiopharm.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Emissary</T><A>http://www.emissary.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Encapsia</T><A>https://encapsia.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Fovéa</T><A>https://popsicube-fovea.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>genae</T><A>https://www.genae.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Harrison Clinical Research</T><A>http://www.harrisonclinical.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Health Decision</T><A>https://www.healthdec.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Icon Clinical Research</T><A>https://www.iconclinical.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>IMM Recherche</T><A>https://www.imm-recherche.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>International Drug development</T><A>http://www.idd-sa.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>IQVIA</T><A>https://www.iqvia.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Keyrus Life Science</T><A>https://www.keyruslifescience.com/en/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Lifetree Clinical Research</T><A>https://www.lifetreeresearch.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>MDS Pharma services</T><A>http://www.mdsps.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Medibridge</T><A>http://www.medibridge.fr</A><L>fr</L><F>HTML</F></X></ITEM>
      <ITEM><X status='dead'><T>Mediscan</T><A>http://www.mediscan-orp.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Omnicare Clinical Research</T><A>http://www.omnicarecr.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Parexel International</T><A>https://www.parexel.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>PPD</T><A>https://www.ppdi.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>PRA International</T><A>http://www.prainternational.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>WuXi Clinical</T><A>https://www.wuxiclinical.com/?lang=en</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Quanta Medical</T><A>https://www.quanta-medical.com/</A><L>fr</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>S-Clinica</T><A>https://www.s-clinica.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Syneos Health</T><A>https://www.syneoshealth.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Target Health</T><A>https://www.targethealth.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Umanis</T><A>http://www.groupeumanis.com</A><L>fr</L><F>HTML</F></X></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Imaging Core Lab</TITLE>
      <ITEM><X><T>BioClinica</T><A>https://bioclinica.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>BioTelemetry</T><A>https://www.gobio.com/</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>Certus</T><A>http://www.certusintl.com</A><L>en</L><F>HTML</F></X></ITEM>
      <ITEM><X><T>WorldCare Clinical</T><A>https://www.wcclinical.com/</A><L>en</L><F>HTML</F></X></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Vendors</TITLE>
      <ITEM><BLIST><TITLE>EDC/ePRO</TITLE>
        <ITEM><BLIST><TITLE>Lists</TITLE>
          <ITEM><X><T>Eco EDC Survey</T><A>http://edcmarket.appspot.com</A><L>fr</L><F>HTML</F></X></ITEM>
        </BLIST></ITEM>
        <ITEM><X><T>Airon Telematica</T><A>https://www.air-tel.it/</A><L>en</L><F>HTML</F></X> (AirTel)</ITEM>
        <ITEM><X><T>Almac Group</T><A>https://www.almacgroup.com/</A><L>en</L><F>HTML</F></X> (iTrial EDC)</ITEM>
        <ITEM><X><T>Axiom Real-Time Metrics</T><A>https://www.axiommetrics.com</A><L>en</L><F>HTML</F></X> (GO<SUP>3</SUP>)</ITEM>
        <ITEM><X><T>Cisiv</T><A>https://www.cisiv.com/</A><L>en</L><F>HTML</F></X> (Baseline Plus)</ITEM>
        <ITEM><X><T>Clincase</T><A>https://www.clincase.com/</A><L>en</L><F>HTML</F></X> (clincase)</ITEM>
        <ITEM><X><T>Clinical Ink</T><A>https://www.clinicalink.com/</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X status='zombie'><T>Clinical Trial Endpoint</T><A>http://www.ctep.eu</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>Clinipace</T><A>https://www.clinipace.com/</A><L>en</L><F>HTML</F></X> (TEMPO)</ITEM>
        <ITEM><X><T>ClinIT</T><A>http://www.clinit.net</A><L>en</L><F>HTML</F></X> (TRI@L-IT)</ITEM>
        <ITEM><X><T>CompleWare</T><A>https://www.compleware.com/</A><L>en</L><F>HTML</F></X> (WebCRF)</ITEM>
        <ITEM><X><T>Datatrak</T><A>http://www.datatrak.net</A><L>en</L><F>HTML</F></X> (DATATRAK eClinical)</ITEM>
        <ITEM><X><T>Datatrial</T><A>https://www.datatrial.com/</A><L>en</L><F>HTML</F></X> (nowEDC)</ITEM>
        <ITEM><X><T>DSG</T><A>http://www.dsg-us.com</A><L>en</L><F>HTML</F></X> (eCaseLink)</ITEM>
        <ITEM><X><T>DZS Software Solutions</T><A>https://dzs.com/</A><L>en</L><F>HTML</F></X> (ClinPlus)</ITEM>
        <ITEM><X><T>e-novex</T><A>http://www.e-novex.com</A><L>en</L><F>HTML</F></X> (e-capture.net)</ITEM>
        <ITEM><X><T>eResearchTechnology</T><A>https://www.ert.com/</A><L>en</L><F>HTML</F></X> (EDC Now!)</ITEM>
        <ITEM><X><T>ERT</T><A>https://www.ert.com</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>Evado</T><A>https://www.evado.com/</A><L>fr</L><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>formedix</T><A>https://www.formedix.com/</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>Forte</T><A>https://forteresearch.com/</A><L>en</L><F>HTML</F></X> (OnCore)</ITEM>
        <ITEM><X><T>Fortress Medical Systems</T><A>https://www.fortressmedical.com/</A><L>en</L><F>HTML</F></X> (Clindex)</ITEM>
        <ITEM><X><T>Infotech Soft</T><A>http://www.infotechsoft.com/</A><L>en</L><F>HTML</F></X> (Aspect)</ITEM>
        <ITEM><X><T>Instem</T><A>https://www.instem.com/</A><L>en</L><F>HTML</F></X> (Alphadas)</ITEM>
        <ITEM><X><T>Kayentis</T><A>https://kayentis.com/</A><L>fr</L><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>Lincoln</T><A>https://www.lincoln.fr/</A><L>fr</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>Medidata</T><A>https://www.medidata.com/</A><L>en</L><F>HTML</F></X> (Rave):
          <X><T>SEC filling</T><A>https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001118023</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>Medrio</T><A>https://medrio.com/</A><L>en</L><F>HTML</F></X> (Medrio)</ITEM>
        <ITEM><X><T>MetNet Solutions</T><A>https://www.mednetsolutions.com/</A><L>en</L><F>HTML</F></X> (ENLIGHTEN)</ITEM>
        <ITEM><X><T>Nextrials</T><A>https://www.nextrials.com/</A><L>en</L><F>HTML</F></X> (Prism)</ITEM>
        <ITEM><X><T>Octogon Research Solutions</T><A>https://www.octagonresearch.com/</A><L>en</L><F>HTML</F></X> (ViewPoint FUSE )</ITEM>
        <ITEM><X><T>OmniComm Systems</T><A>https://www.omnicomm.com/</A><L>en</L><F>HTML</F></X> (TrialMaster)</ITEM>
        <ITEM><X><T>Oracle Clinical</T><A>https://www.oracle.com/industries/life-sciences/</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>Phoenix Software International</T><A>https://phoenixsoftware.com/entrypoint</A><L>en</L><F>HTML</F></X> (Entrypoint Plus)</ITEM>
        <ITEM><X><T>Prelude Dynamics</T><A>https://www.preludedynamics.com/</A><L>en</L><F>HTML</F></X> (Vision)</ITEM>
        <ITEM><X><T>REDCap Consortium</T><A>https://www.project-redcap.org/</A><L>en</L><F>HTML</F></X> (RedCap)</ITEM>
        <ITEM><X><T>Studytrax</T><A>https://www.studytrax.com//</A><L>en</L><F>HTML</F></X> (StudyTRAX)</ITEM>
        <ITEM><X status='dead'><T>SigmaSoft</T><A>http://www.sigmasoftintl.com</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>Syne qua non</T><A>https://www.synequanon.com/</A><L>en</L><F>HTML</F></X> (Syneclin II)</ITEM>
        <ITEM><X status='dead'><T>TENALEA</T><A>https://www.tenalea.com</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>TrialStat</T><A>https://www.trialstat.com/</A><L>en</L><F>HTML</F></X> (ClinicalAnalytics) now part of Clinsys Clinical Research</ITEM>
        <ITEM><X><T>Velos</T><A>https://www.velos.com/</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>Viedoc Technologies</T><A>https://www.viedoc.com</A><L>en</L><F>HTML</F></X> (Viedoc)</ITEM>
        <ITEM><X><T>XClinical</T><A>https://xclinical.com/</A><L>en</L><F>HTML</F></X> (Marvin)</ITEM>
        <ITEM><X><T>XML4Pharma</T><A>http://www.xml4pharma.com</A><L>en</L><F>HTML</F></X></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Image management</TITLE>
        <ITEM><X><T>AG Mednet</T><A>https://www.agmednet.com/</A><L>en</L><F>HTML</F></X></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Randomization</TITLE>
        <ITEM><X><T>Cytel</T><A>https://www.cytel.com/</A><L>en</L><F>HTML</F></X></ITEM>
        <ITEM><X><T>AB Plus</T><A>https://www.ab-plus.com/randomisation_ivrs/</A><L>fr</L><F>HTML</F></X></ITEM>
      </BLIST></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Site assessment</TITLE>
      <ITEM><X><T>Scientific Software Tools (VISTA Surveys)</T><A>http://www.vistasurveys.com</A><L>en</L><F>HTML</F></X></ITEM>
    </BLIST></ITEM>
  </SLIST></ITEM>
  <ITEM><BLIST><TITLE>Articles and videos</TITLE>
    <ITEM><BLIST><TITLE>EDC/ePRO market</TITLE>
      <ITEM><ARTICLE><X status='dead'><T>Life on EDC Street</T><A>https://www.bio-itworld.com/issues/2007/oct/growing-edc-market/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2007</YEAR><MONTH>10</MONTH></DATE><COMMENT>An analysis of who are the biggest providers on the EDC market.</COMMENT></ARTICLE></ITEM>
      <ITEM><BLIST><TITLE>Afferenz</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Trianz Buys Afferenz</T><ST>Consultants Buy Eclinical Firm</ST><A>http://www.clinpage.com/article/consultants_buy_eclinical_firm/C10</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>11</MONTH><DAY>18</DAY></DATE><COMMENT>Venkatesan Thangaraj, Afferenz president, gives some information on his product as his company is bought by Trianz.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Almac</TITLE>
        <ITEM><ARTICLE><X><T>Almac Completes First Paperless Client Audit</T><A>https://www.almacgroup.com/news/almac-completes-first-paperless-client-audit/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>2</MONTH><DAY>24</DAY></DATE><COMMENT>Almac's auditable documentation (SOP, SDLC…) is now fully electronic.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Akaza Research</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>No-Cost EDC Rapidly Catching On</T><A>https://www.bio-itworld.com/ecliniqua/2008/06/02/akaza-openclinica-no-cost-edc.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2006</YEAR><MONTH>6</MONTH><DAY>2</DAY></DATE><COMMENT>OpenClinica is getting some attention.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>OpenClinica 2.5 Targets Industry-Sponsored Trials</T><A>https://www.bio-itworld.com/ecliniqua/2008/10/27/openclinica-2point5.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR><MONTH>10</MONTH><DAY>27</DAY></DATE><COMMENT>The new 2.5 release: improved edit-checks, query overview, faster data extraction…</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>OpenClinica Community Virtual Forum December 16th, 2008</T><A>http://www.openclinica.org/dokuwiki/doku.php?id=publicwiki:virtualforum:2008dec16</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>12</MONTH><DAY>16</DAY></DATE><COMMENT>The minutes of the users/developers meeting.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Open Source EDC: answer to the Pharma challenges ?</T><A>http://blog.evidence-performance.com/2009/02/23/open-source-edc/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Barbara</FIRSTNAME><LASTNAME>Zwick</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Ben</FIRSTNAME><LASTNAME>Baumann</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>2</MONTH><DAY>23</DAY></DATE><COMMENT>A marketing speech explaining that open source is better than proprietary solutions.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE predecessor='http://blog.evidence-performance.com/2009/02/23/open-source-edc/'><X quality='1'><T>Open Source eClinical - Myths &amp; Facts</T><A>https://ecdms.blogspot.com/2009/03/open-source-eclinical-myths-facts.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>3</MONTH><DAY>8</DAY></DATE><COMMENT>A good answer to the previous interview: some arguments of <AUTHOR><FIRSTNAME>Ben</FIRSTNAME><LASTNAME>Baumann</LASTNAME></AUTHOR> are simply impractical/ridiculous.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>BioClinica</TITLE>
        <ITEM><BLIST><TITLE>Phoenix Data Systems</TITLE>
          <ITEM><ARTICLE><X><T>Phoenix Data sees its role as service provider growing larger</T><A>https://www.bizjournals.com/philadelphia/stories/2006/04/03/newscolumn1.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Peter</FIRSTNAME><LASTNAME>Key</LASTNAME></AUTHOR><DATE><YEAR>2006</YEAR><MONTH>3</MONTH><DAY>31</DAY></DATE><COMMENT>The current status of PDS.</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X><T>Bio-Imaging Technologies buys Phoenix Data Systems</T><A>https://bizjournals.com/philadelphia/stories/2008/03/24/daily9.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>3</MONTH><DAY>25</DAY></DATE><COMMENT>The title says everything.</COMMENT></ARTICLE></ITEM>
          <ITEM><ARTICLE><X status='dead'><T>Chris Connor to Drive Product Development at PDS</T><A>https://www.bio-itworld.com/ecliniqua/2008/10/20/title.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>10</MONTH><DAY>20</DAY></DATE><COMMENT>An interview of the new PDS director of product development.</COMMENT></ARTICLE></ITEM>
        </BLIST></ITEM>
        <ITEM><ARTICLE><X><T>BIOCLINICA™ ACQUIRES CARDIONOW FROM AGFA HEALTHCARE -Adds Proven Solution for Secure, Regulatory Compliant Electronic Transmission and Analysis of Medical Images for Clinical Trials-</T><A>https://www.bioclinica.com/assets/Uploads/Press-Releases/BioClinica-Acquires-CardioNow-from-AGFA-Healthcare.pdf</A><L>en</L><F>PDF</F></X><DATE><YEAR>2009</YEAR><MONTH>9</MONTH><DAY>1</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>BioClinica: Why Supplies Matter</T><A>http://www.clinpage.com/article/bioclinica_why_supplies_matter/C10</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>9</MONTH><DAY>16</DAY></DATE><COMMENT>BioClinica acquires Tourtellotte.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>BioClinica Acquires Tourtellotte Solutions</T><A>https://www.appliedclinicaltrialsonline.com/view/bioclinica-acquires-tourtellotte-solutions</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Kevin</FIRSTNAME><LASTNAME>Davies</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>9</MONTH><DAY>21</DAY></DATE><COMMENT>A shorter article on the same subject.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>BioClinica Adds Image Transport to its Integrated Product Suite</T><A>https://www.bio-itworld.com/2009/11/16/bioclinica.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>11</MONTH><DAY>16</DAY></DATE><COMMENT>Mark Weinstein speaks about CardioNow.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>BioClinica Acquires TranSenda International, LLC</T><ST>Adds Clinical Trial Management Software With Microsoft Office Interoperability</ST><A>https://www.bioclinica.com/news-events/press-releases/bioclinica-acquires-transenda-international-llc</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>3</MONTH><DAY>26</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>BioClinica Acquires Cephalon’s U.S. Data Management Team</T><A>https://www.bio-itworld.com/2010/04/19/bioclinica-cephalon.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>4</MONTH><DAY>19</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>$400 Million Niche</T><ST>Imaging Core Lab Nuances</ST><A>http://www.clinpage.com/article/imaging_core_lab_nuances</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>9</MONTH><DAY>3</DAY></DATE><COMMENT>Mark Weinstein explains that technology is not the only factor, the service (having good project managers, using FedEx if the radiologist wants it…) is also important. He also speaks about the market and the difficulties for new comers.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Cisiv</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Interview: Dominic Farmer, Cisiv CEO</T><A>https://eclinicalopinion.blogspot.com/2009/07/interview-dominic-farmer-cisiv-ceo.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Dominic</FIRSTNAME><LASTNAME>Farmer</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>7</MONTH><DAY>8</DAY></DATE><COMMENT>An interview of Cisiv's CEO: the history and particularities of Baseline Plus, the EDC market…</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Datatrak</TITLE>
        <ITEM><ARTICLE><X><T>CEO Spotlight: Jeffrey Green, DATATRAK International, Inc.</T><A>http://www.sterlingreport.net/articles/article222.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Angel</FIRSTNAME><LASTNAME>Mehta</LASTNAME></AUTHOR><DATE><YEAR>2006</YEAR><MONTH>6</MONTH><DAY>2</DAY></DATE><COMMENT>An interview of Datatrak's CEO.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>DATATRAK Patent #7,464,087</T><A>https://eclinicalopinion.blogspot.com/2009/03/datatrak-patent-7464087.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>3</MONTH><DAY>12</DAY></DATE><COMMENT>A critic of Datatrack's "Method and system of unifying data" patent.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>etrials Worldwide</TITLE>
        <ITEM><ARTICLE><X><T>Bio-Imaging Technologies to Acquire eTrials Worldwide</T><A>https://www.bioclinica.com/assets/Uploads/Press-Releases/Bio-Imaging-Technologies-to-Acquire-etrials-Worldwide.pdf</A><L>en</L><F>PDF</F></X><DATE><YEAR>2009</YEAR><MONTH>5</MONTH><DAY>5</DAY></DATE><COMMENT>The title of this PR says all.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Etrials Purchase Would Make BioClinica Number Three EDC Player</T><A>https://www.bio-itworld.com/news/2009/05/08/etrials-acquisition.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>5</MONTH><DAY>8</DAY></DATE><COMMENT>One of the numerous articles on the acquisition.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>BioClinica to buy Etrials Worldwide</T><A>https://eclinicalopinion.blogspot.com/2009/05/bioclinica-to-buy-etrials-worldwide.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>5</MONTH><DAY>11</DAY></DATE><COMMENT>A short analysis on the acquisition.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>etrials Worldwide Announces Q1 2009 Results</T><A>https://eclinicalopinion.blogspot.com/2009/05/etrials-worldwide-announces-q1-2009.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>5</MONTH><DAY>12</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Merge Healthcare Announces Definitive Agreement with etrials Worldwide</T><A>https://www.businesswire.com/news/home/20090601005551/en</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>6</MONTH><DAY>1</DAY></DATE><COMMENT>Finally, Merge does the deal.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>flexcipio</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>eClinical Technologies perspective : Interview with a dynamic CTO</T><A>http://blog.evidence-performance.com/2008/12/19/eclinical-technologies-perspective/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Alexandre</FIRSTNAME><LASTNAME>Durand-Salmon</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Vincent</FIRSTNAME><LASTNAME>Wautelet</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR><MONTH>11</MONTH><DAY>3</DAY></DATE><COMMENT>An interview of flexcipio's CTO who is advocating the use of standards in order to ensure interconnectivity and to avoid being locked down to a vendor. He is suggesting pharma companies to work with young innovative vendors.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>ICON</TITLE>
        <ITEM><ARTICLE><X><T>ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies</T><ST>First Commercial Imaging Lab to Offer Quantitative Coronary Angiographic Analysis with Integrated eCRF</ST><A>https://investor.iconplc.com/news-releases/news-release-details/icon-medical-imaging-launches-new-service-boost-reliability/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>8</MONTH><DAY>11</DAY></DATE><COMMENT>Integration of QCA.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication</T><ST>Enables Sponsors to Comply with Recent FDA Guidance on Diabetes Trials</ST><A>https://investor.iconplc.com/news-releases/news-release-details/icon-delivers-new-electronic-solution-expedite-clinical-trial/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>1</MONTH><DAY>26</DAY></DATE><COMMENT>Adjudication with DICOM images.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Invivodata</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Differentiation Via Psychometrics</T><ST>Ediaries &amp; The Z Axis</ST><A>http://www.clinpage.com/article/ediaries_and_the_z_axis</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>8</MONTH><DAY>9</DAY></DATE><COMMENT>Jean Paty claims that sponsors will need, per FDA request, to properly measure patient reported experience.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Kayentis</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Kayentis Makes Push into North America with EDC Alternative</T><A>https://www.bio-itworld.com/ecliniqua/2008/11/03/kayentis-digital-pen-and-paper.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR><MONTH>11</MONTH><DAY>3</DAY></DATE><COMMENT>A short presentation of Kayentis "digital pen and paper" technology and its entry on the US market.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Kayentis: Back to The Future</T><A>http://www.clinpage.com/article/kayentis_back_to_the_future</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>11</MONTH><DAY>24</DAY></DATE><COMMENT>A similar presentation of Kayentis technology.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Medidata</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Wyeth Selects Medidata Rave as Its EDC Standard</T><A>https://www.bio-itworld.com/newsitems/2007/nov/05-wyeth-selects-medidata-rave-for-edc/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2007</YEAR><MONTH>11</MONTH><DAY>7</DAY></DATE><COMMENT>Medidata is becoming a more and more prominent EDC vendor.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Medidata Solutions Expands Clinical Trial Technology Offering with Acquisition of Fast Track Systems</T><A>https://www.medidata.com/en/press-releases/medidata-solutions-expands-clinical-trial-technology-offering-acquisition-fast-track-systems/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>3</MONTH><DAY>17</DAY></DATE><COMMENT>Medidata acquires FastTrack.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Medidata Solutions Launches Online Developer Community to Foster Collaborative Innovation</T><A>https://www.medidata.com/en/press-releases/medidata-solutions-launches-online-developer-community-foster-collaborative-innovation/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>10</MONTH><DAY>27</DAY></DATE><COMMENT>Medidata creates a community around its Rave Web Services API.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Medidata Files for IPO</T><A>https://eclinicalopinion.blogspot.com/2009/01/medidata-files-for-ipo.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>1</MONTH><DAY>26</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Early Trial Planning Solutions</T><A>https://www.bio-itworld.com/2010/06/16/medidata.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>6</MONTH><DAY>21</DAY></DATE><COMMENT>Medidata presents Grants Manager 3.0 and Balance, a RTSM to simulate and manage randomizations.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>What's Our Number?</T><ST>Medidata EDC Enhancements</ST><A>http://www.clinpage.com/article/medidata_edc_enhancements/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>10</MONTH><DAY>22</DAY></DATE><COMMENT>The new features of Grants Manager and Rave: centralized user database, planned partial SDV, evaluation of the trial complexity, NCI deal…</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Merge</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>7 Questions For Core Labs 66 Modern Imaging Benchmarks</T><A>http://www.clinpage.com/article/modern_imaging_benchmarks</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>8</MONTH><DAY>18</DAY></DATE><COMMENT>Merge claims that digital image transfer and management systems, such as its own, will change the game, Imaging Core Labs may not be necessary anymore.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>OmniComm</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>OmniComm Systems buys eResearch EDC Unit</T><A>https://eclinicalopinion.blogspot.com/2009/06/omnicomm-systems-buys-eresearch-edc.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>6</MONTH><DAY>25</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>OmniComm Strives to be a Tier I eClinical Player</T><A>https://www.bio-itworld.com/2009/10/19/OmniComm.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Ann</FIRSTNAME><LASTNAME>Neuer</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>10</MONTH><DAY>20</DAY></DATE><COMMENT>The current status of the company.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Oracle</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>In Conversation: Oracle’s Patti Gaves on EDC and Integration</T><A>https://www.bio-itworld.com/2009/10/05/oracleQ-A.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>10</MONTH><DAY>5</DAY></DATE><COMMENT>The status of the EDC market as seen by Patti Gaves of Oracle Health Sciences.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Perceptive Informatics / ClinPhone</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Perceptive Informatics Upgrades TrialWorks CTMS, DataLabs EDC</T><A>https://www.bio-itworld.com/ecliniqua/2008/11/24/perceptive-upgrades-trialworks-datalabs.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR><MONTH>11</MONTH><DAY>24</DAY></DATE><COMMENT>New releases of TrialWorks and DataLabs.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Perceptive &amp; MCC</T><ST>For Imaging, Standard Metrics</ST><A>http://www.clinpage.com/article/for_imaging_standard_metrics/C15</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>6</MONTH><DAY>24</DAY></DATE><COMMENT>Perceptive is using Metrics Champion Consortium metrics to improve and demonstrate its quality.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Phase Forward</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Data Accelerator</T><ST>Phase Forward Touts Akamai</ST><A>http://www.clinpage.com/article/phase_forward_touts_akamai</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>8</MONTH><DAY>18</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Phase Forward Uses Akamai's Service To Speed the Web</T><A>https://eclinicalopinion.blogspot.com/2008/09/phase-forward-uses-akamais-service-to.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>9</MONTH><DAY>8</DAY></DATE><COMMENT>An analysis of the interest of Akamai for an EDC comapny.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Clarix IRT Becomes Property of Phase Forward</T><A>https://www.bio-itworld.com/ecliniqua/2008/09/29/phase-forward-acquires-clarix.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR><MONTH>9</MONTH><DAY>29</DAY></DATE><COMMENT>Yet another acquisition of Phase Forward.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Paul Bleicher, M.D. - Founder and former Chairman, Phase Forward</T><A>https://www.bio-itworld.com/lsw/paul_bleicher</A><L>en</L><F>Flash Video</F><DURATION><MINUTE>16</MINUTE><SECOND>44</SECOND></DURATION></X><AUTHOR><FIRSTNAME>Paul</FIRSTNAME><LASTNAME>Bleicher</LASTNAME></AUTHOR><AUTHOR><FIRSTNAME>Kevin</FIRSTNAME><LASTNAME>Davies</LASTNAME></AUTHOR><DATE><YEAR>2008</YEAR><MONTH>12</MONTH></DATE><COMMENT>An interview of Paul Bleicher: the current state of EDC, the past and future of Phase Forward, and his new EHR company.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Phase Forward Helps FDA, DoD Monitor Drug Safety</T><A>https://www.bio-itworld.com/ecliniqua/2009/01/26/phase-forward-fda-drug-safety.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>1</MONTH><DAY>26</DAY></DATE><COMMENT>Digging in the DOD health record database to analyze possible safety issues.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>EDC Redesign</T><ST>Phase Forward Makeover</ST><A>http://www.clinpage.com/article/phase_forward_makeover/C5</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>6</MONTH><DAY>23</DAY></DATE><COMMENT>Some information about the new InForm release.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Phase Forward Acquisitions Push Broader Clinical Trial Solutions</T><A>https://www.bio-itworld.com/2009/08/17/phase-forward.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Ann</FIRSTNAME><LASTNAME>Neuer</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>8</MONTH><DAY>17</DAY></DATE><COMMENT>Phase Forward is buying companies in order to provide a complete clinical trial solution. It also releases a new InForm version: GTM (Global Trial Management).</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Oracle Buys Phase Forward</T><ST>Expands Oracle's Solutions for the Life Sciences and Healthcare Industries</ST><A>http://oracle.com/us/corporate/press/068204</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>4</MONTH><DAY>16</DAY></DATE><COMMENT>The title says all.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Integrating InForm EDC at Dana-Farber Cancer Institute</T><A>https://www.bio-itworld.com/2010/05/04/dfci-edc.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>5</MONTH><DAY>4</DAY></DATE><COMMENT>The Dana-Farber/Harvard Cancer Center has chosen Phase Forward solution.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>PHT</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>PHT Scales for Global ePRO Business by Updating StudyWorks</T><A>https://www.bio-itworld.com/2010/01/19/ePRO.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Ann</FIRSTNAME><LASTNAME>Neuer</LASTNAME></AUTHOR><DATE><YEAR>2010</YEAR><MONTH>1</MONTH><DAY>19</DAY></DATE><COMMENT>The new StudyWorks release includes reports to manage and track devices.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>REDCap Consortium</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>REDCap: EDC for Academic Research</T><A>https://eclinicalopinion.blogspot.com/2010/03/redcap-edc-for-academic-research.html</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>3</MONTH><DAY>18</DAY></DATE><COMMENT>An overview of REDCap, an EDC system for academic research.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Scitek</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Obtain Clinically Meaningful Analysis-Ready Data Sooner</T><A>http://sciteksolutions.com/download/edcpro.pdf</A><L>en</L><F>PDF</F></X><AUTHOR><FIRSTNAME>John</FIRSTNAME><LASTNAME>Sun</LASTNAME></AUTHOR><DATE><YEAR>2005</YEAR><MONTH>11</MONTH><DAY>12</DAY></DATE><COMMENT>A presentation of edc<SUP>pro</SUP> 2.0.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>SigmaSoft</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>SigmaSoft and Netrics Partner to Improve Regulatory Coding Process</T><A>https://www.bio-itworld.com/newsitems/2007/nov/05-sigmasoft-netrics-partner/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Ann</FIRSTNAME><LASTNAME>Neuer</LASTNAME></AUTHOR><DATE><YEAR>2007</YEAR><MONTH>11</MONTH><DAY>7</DAY></DATE><COMMENT>SigmaSoft uses Netrics' technology to implement fuzzy matching in the coding process.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>TrialStat / Clinsys Clinical Research</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>TrialStat: ClinicalAnalytics 4 Will Be ‘Disruptive’</T><A>https://www.bio-itworld.com/newsitems/2007/dec/03-trialstat-ca4/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2007</YEAR><MONTH>12</MONTH><DAY>6</DAY></DATE><COMMENT>ClinicalAnalytics 4 is released.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Celtic House company in receivership</T><A>http://www.obj.ca/Other/Archives/2008-11-07/article-2254279/Celtic-House-company-in-receivership</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>11</MONTH><DAY>7</DAY></DATE><COMMENT>The debt status of TrialStat.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Clinsys Ecstatic over TrialStat CA EDC Acquisition</T><A>https://www.bio-itworld.com/ecliniqua/2009/01/26/clinsys-acquires-trialstat.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>1</MONTH><DAY>26</DAY></DATE><COMMENT>Clinsys acquires TrialStat ClinicalAnalytics.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Velos</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Velos eResearch Has Multi-Purpose Appeal to Academic Sites</T><A>https://www.bio-itworld.com/2009/10/19/velos.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>10</MONTH><DAY>20</DAY></DATE><COMMENT>A description of Velos eResearch linking EDC and EMR.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
    </BLIST></ITEM>
    <ITEM><BLIST><TITLE>Other companies</TITLE>
      <ITEM><BLIST><TITLE>AG Mednet</TITLE>
        <ITEM><ARTICLE><X><T>Phase Forward and AG Mednet Form Alliance to Develop Integrated Imaging Offering</T><ST>New Offering Will Provide Capabilities to Transport, Track and Manage the Status of Clinical Trial Images from within the InFormTM ITM System, Reducing the Time and Cost Associated with Medical Image Transport</ST><A>https://agmednet.com/phase-forward-and-ag-mednet-form-alliance-to-develop-integrated-imaging-offering/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>6</MONTH><DAY>23</DAY></DATE><COMMENT>AG MedNet gets an aliance with Phase Forward.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>AG Mednet: Pictures, Moved</T><A>http://www.clinpage.com/article/ag_mednet_pictures_moved/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2008</YEAR><MONTH>7</MONTH><DAY>16</DAY></DATE><COMMENT>A (rather marketing) presentation of AG MedNet solution.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>Perceptive Informatics Establishes Alliance with AG Mednet to Bring Greater Efficiency and Quality to Medical Imaging-Based Trials</T><ST>Marshall Edwards Accelerates Study Timeline and Experiences Cost Reduction through Perceptive Alliance with AG Mednet</ST><A>https://agmednet.com/perceptive-informatics-establishes-alliance-with-ag-mednet-to-bring-greater-efficiency-and-quality-to-medical-imaging-based-trials/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>2</MONTH><DAY>4</DAY></DATE><COMMENT>Perceptive is using AG Mednet's Diagnostic Imaging Network.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X status='dead'><T>Extracting Greater Efficiency From Clinical Trial Processes</T><A>http://www.agmednet.com/press/documents/PULSE-ExtractingGreaterEfficiencyFromClinicalTrialProcesses.pdf</A><L>en</L><F>PDF</F></X><AUTHOR><FIRSTNAME>Abraham</FIRSTNAME><LASTNAME>Gutman</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>4</MONTH></DATE><COMMENT>BioImaging is using AG Mednet.</COMMENT></ARTICLE></ITEM>
        <ITEM><ARTICLE><X><T>AG Mednet Announces Milestones In Electronic Image Submission Compliance And Broad Worldwide Adoption Of Its Network Platform</T><ST>Compliance and quality assurance features and tools reduce transport costs and decrease site queries. Adaptive and Eligibility trials are finally made practical realities.</ST><A>https://agmednet.com/ag-mednet-announces-milestones-in-electronic-image-submission-compliance-and-broad-worldwide-adoption-of-its-network-platform/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2009</YEAR><MONTH>11</MONTH><DAY>2</DAY></DATE><COMMENT>BioImaging is using AG Mednet.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>ClearTrial</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>ClearTrial Adds Project Tracking Product to Integrated Software Suite</T><A>https://www.bio-itworld.com/2009/11/16/cleartrial.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>11</MONTH><DAY>16</DAY></DATE><COMMENT>ClearTrial Track enables the tracking of the project cost.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Cytel</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Cytel, FDA to Develop Software for Bayesian Device Trials</T><A>https://www.bio-itworld.com/2009/08/24/cytel-fda.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>8</MONTH><DAY>24</DAY></DATE><COMMENT>Cytel signed a CRADA with the FDA in order to provide a tool to verify Bayesian trial submissions.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Insightful</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Insightful Makes Sharing Graphs Easier</T><A>https://www.bio-itworld.com/newsitems/2007/dec/31-icg-graph-sharing-software/</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>John</FIRSTNAME><LASTNAME>Russell</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>4</MONTH></DATE><COMMENT>Insightful releases iCG, a tool for sharing statistical graphs.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Quintiles</TITLE>
        <ITEM><ARTICLE><X status='dead'><T>Data Integration Tool</T><ST>Quintiles’ Infosario System</ST><A>http://www.clinpage.com/article/quintiles_infosario_system/</A><L>en</L><F>HTML</F></X><DATE><YEAR>2010</YEAR><MONTH>8</MONTH><DAY>3</DAY></DATE><COMMENT>Quintiles has implemented a Web-based software which allows to navigate among data coming from diverse clinical trial systems (EDC, ePRO, lab…).</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
      <ITEM><BLIST><TITLE>Target Health</TITLE>
        <ITEM><ARTICLE><X><T>EDC Co-Development a Win-Win for Ferring, Target Health</T><A>https://www.dropbox.com/s/g0ysxesk8wf642z/20090526-ferring-target-health-co-development.pdf</A><L>en</L><F>PDF</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>5</MONTH><DAY>26</DAY></DATE><COMMENT>Target Health, a CRO, has built an EDC system in house.</COMMENT></ARTICLE></ITEM>
      </BLIST></ITEM>
    </BLIST></ITEM>
    <ITEM><ARTICLE><X status='dead'><T>Sponsors Run to goBalto.com to Size Up Service Providers</T><A>https://www.bio-itworld.com/2009/08/24/gobalto.html</A><L>en</L><F>HTML</F></X><AUTHOR><FIRSTNAME>Deborah</FIRSTNAME><LASTNAME>Borfitz</LASTNAME></AUTHOR><DATE><YEAR>2009</YEAR><MONTH>8</MONTH><DAY>24</DAY></DATE><COMMENT>A company review site for the drug development industry.</COMMENT></ARTICLE></ITEM>
  </BLIST></ITEM>
</LLIST>
</CONTENT>
</PAGE>